High quality & competitive price
Quality control
Fast feedback
Prompt shipment
Search
Imatinib mesylate is used in the treatment of chronic myelogenous leukemia. Imatinib mesylate inhibits Bcr-Abl tyrosine kinase at the cellular level, and can selectively inhibit the proliferation and induction of apoptosis of fresh cells in patients with Bcr-Abl positive cell lines, Ph-positive chronic myeloid leukemia and acute lymphoblastic leukemia. Imatinib mesylate can also inhibit platelet-derived growth factor (PDGF) receptors, stem cell factor (SCF), and tyrosine kinases of c-Kit receptors, thereby inhibiting cell behavior mediated by PDGF and stem cell factors.
| Items | Specification |
| Product name | Imatinib mesylate |
| CAS | 220127-57-1 |
| Appearance | White powder |
| Assay | ≥98% |
| Molecular Formula | C30H35N7O4S |
| Molecular Weight | 589.71 |
| EINECS | 606-892-3 |
| Product parameters | |
| Cas number: | 220127-57-1 |
| Appearance: | White powder |
| Purity: | 99%min |
| Package details: | 25kg/drum |
| Brand: | Fortunachem |


Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail:
English
Español
français
العربية